109 related articles for article (PubMed ID: 2436827)
1. Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heart.
Bajaj AK; Kopelman HA; Wikswo JP; Cassidy F; Woosley RL; Roden DM
Circulation; 1987 May; 75(5):1065-73. PubMed ID: 2436827
[TBL] [Abstract][Full Text] [Related]
2. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
Roden DM; Iansmith DH; Woosley RL
J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
[TBL] [Abstract][Full Text] [Related]
3. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
Costard-Jäckle A; Franz MR
J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
[TBL] [Abstract][Full Text] [Related]
4. Effects of sympathetic stimulation on use dependence of lidocaine, mexiletine, and quinidine in an intact canine model.
Newman D; Herre JM; Chin M; Scheinman MM; Franz M; Katzung B
Can J Physiol Pharmacol; 1992 Feb; 70(2):219-24. PubMed ID: 1325863
[TBL] [Abstract][Full Text] [Related]
5. Electropharmacologic synergism with mexiletine and quinidine.
Duff HJ; Kolodgie FD; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1986; 8(4):840-6. PubMed ID: 2427827
[TBL] [Abstract][Full Text] [Related]
6. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.
Costard-Jaeckle A; Liem LB; Franz MR
J Cardiovasc Pharmacol; 1989 Dec; 14(6):810-7. PubMed ID: 2481766
[TBL] [Abstract][Full Text] [Related]
7. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
Duff HJ; Rahmberg M; Sheldon RS
J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588
[TBL] [Abstract][Full Text] [Related]
8. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
Valois M; Sasyniuk BI
Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
[TBL] [Abstract][Full Text] [Related]
9. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
[TBL] [Abstract][Full Text] [Related]
10. Mexiletine-quinidine in isolated hearts: an interaction involving the sodium channel.
Duff HJ; Cannon NJ; Sheldon RS
Cardiovasc Res; 1989 Jul; 23(7):584-92. PubMed ID: 2557155
[TBL] [Abstract][Full Text] [Related]
11. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
Feld GK; Venkatesh N; Singh BN
Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
[TBL] [Abstract][Full Text] [Related]
13. Effects of simultaneous administration of mexiletine and quinidine on the electrophysiologic parameters of canine Purkinje fibers.
Burke GH; Loukides JE; Berman ND
J Cardiovasc Pharmacol; 1986; 8(6):1138-43. PubMed ID: 2434738
[TBL] [Abstract][Full Text] [Related]
14. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
Nattel S
J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
[TBL] [Abstract][Full Text] [Related]
15. Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical.
Heath BM; Cui Y; Worton S; Lawton B; Ward G; Ballini E; Doe CP; Ellis C; Patel BA; McMahon NC
J Pharmacol Toxicol Methods; 2011; 63(3):258-68. PubMed ID: 21194571
[TBL] [Abstract][Full Text] [Related]
16. Effects of halothane and quinidine on intracardiac conduction and QTc interval in pentobarbital-anesthetized dogs.
Gallagher JD
Anesth Analg; 1992 Nov; 75(5):688-95. PubMed ID: 1416119
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of mexiletine in man.
Roos JC; Paalman AC; Dunning AJ
Br Heart J; 1976 Dec; 38(12):1262-71. PubMed ID: 1008969
[TBL] [Abstract][Full Text] [Related]
18. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
[TBL] [Abstract][Full Text] [Related]
19. Mexiletine and quinidine in combination in an ischemic model: supra-additive antiarrhythmic and electrophysiologic actions.
Duff HJ; Gault NJ
J Cardiovasc Pharmacol; 1986; 8(4):847-57. PubMed ID: 2427828
[TBL] [Abstract][Full Text] [Related]
20. Mexiletine-quinidine combination: enhanced antiarrhythmic and electrophysiologic activity in the dog.
Duff HJ
J Pharmacol Exp Ther; 1989 May; 249(2):617-22. PubMed ID: 2724143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
